Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1969 1
1970 1
1971 2
1972 3
1973 2
1974 3
1975 11
1976 7
1977 6
1978 2
1979 4
1980 6
1981 1
1982 1
1983 5
1984 4
1985 2
1986 3
1987 1
1989 3
1991 3
1992 3
1993 4
1995 6
1996 1
1998 2
1999 1
2000 1
2001 3
2002 3
2003 2
2004 1
2005 6
2006 4
2007 4
2008 6
2009 2
2010 8
2011 10
2012 7
2013 12
2014 10
2015 14
2016 8
2017 11
2018 10
2019 15
2020 5
2021 9
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

235 results
Results by year
Filters applied: . Clear all
Page 1
PHD3 Loss Promotes Exercise Capacity and Fat Oxidation in Skeletal Muscle.
Yoon H, Spinelli JB, Zaganjor E, Wong SJ, German NJ, Randall EC, Dean A, Clermont A, Paulo JA, Garcia D, Li H, Rombold O, Agar NYR, Goodyear LJ, Shaw RJ, Gygi SP, Auwerx J, Haigis MC. Yoon H, et al. Among authors: agar nyr. Cell Metab. 2020 Aug 4;32(2):215-228.e7. doi: 10.1016/j.cmet.2020.06.017. Epub 2020 Jul 13. Cell Metab. 2020. PMID: 32663458 Free PMC article.
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK, Swanson KR, Kaufmann TJ, Brown PD, Agar NYR, Galanis E, Buckner JC, Elmquist WF. Sarkaria JN, et al. Among authors: agar nyr. Neuro Oncol. 2018 Jan 22;20(2):184-191. doi: 10.1093/neuonc/nox175. Neuro Oncol. 2018. PMID: 29016900 Free PMC article. Review.
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma.
Marin BM, Porath KA, Jain S, Kim M, Conage-Pough JE, Oh JH, Miller CL, Talele S, Kitange GJ, Tian S, Burgenske DM, Mladek AC, Gupta SK, Decker PA, McMinn MH, Stopka SA, Regan MS, He L, Carlson BL, Bakken K, Burns TC, Parney IF, Giannini C, Agar NYR, Eckel-Passow JE, Cochran JR, Elmquist WF, Vaubel RA, White FM, Sarkaria JN. Marin BM, et al. Among authors: agar nyr. Neuro Oncol. 2021 Dec 1;23(12):2042-2053. doi: 10.1093/neuonc/noab133. Neuro Oncol. 2021. PMID: 34050676 Free PMC article.
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma.
Braun CJ, Stanciu M, Boutz PL, Patterson JC, Calligaris D, Higuchi F, Neupane R, Fenoglio S, Cahill DP, Wakimoto H, Agar NYR, Yaffe MB, Sharp PA, Hemann MT, Lees JA. Braun CJ, et al. Among authors: agar nyr. Cancer Cell. 2017 Oct 9;32(4):411-426.e11. doi: 10.1016/j.ccell.2017.08.018. Epub 2017 Sep 28. Cancer Cell. 2017. PMID: 28966034 Free PMC article.
Can 'eugenics' be defended?
Veit W, Anomaly J, Agar N, Singer P, Fleischman DS, Minerva F. Veit W, et al. Among authors: agar n. Monash Bioeth Rev. 2021 Jul;39(1):60-67. doi: 10.1007/s40592-021-00129-1. Epub 2021 May 25. Monash Bioeth Rev. 2021. PMID: 34033008 Free PMC article.
Livedo racemosa.
Sebaratnam DF, Agar N. Sebaratnam DF, et al. Among authors: agar n. Med J Aust. 2017 Oct 16;207(8):327. doi: 10.5694/mja16.01355. Med J Aust. 2017. PMID: 29020898 No abstract available.
Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ. Agar NS, et al. J Clin Oncol. 2010 Nov 1;28(31):4730-9. doi: 10.1200/JCO.2009.27.7665. Epub 2010 Sep 20. J Clin Oncol. 2010. PMID: 20855822
235 results